We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+1.41%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$712M
AUM Growth
+$710M
Cap. Flow
-$649M
Cap. Flow %
-91.27%
Top 10 Hldgs %
6.85%
Holding
408
New
37
Increased
7
Reduced
332
Closed
32

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$9.58M
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.96M
4
SIG icon
Signet Jewelers
SIG
+$1.34M
5
YHOO
Yahoo Inc
YHOO
+$1.29M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$14.4M
2
MSFT icon
Microsoft
MSFT
+$7.81M
3
AAPL icon
Apple
AAPL
+$6.72M
4
GILD icon
Gilead Sciences
GILD
+$5.41M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$5.38M

Sector Composition

Rank Sector Weight
1 Technology 14.08%
2 Financials 13.4%
3 Healthcare 12.23%
4 Consumer Discretionary 11%
5 Industrials 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGEN
326
Agenus
AGEN
$290M
$682K 0.1%
8,583
-7,781
-48% -$607K
KDNY
327
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$682K 0.1%
12,060
+2,668
+28% +$162K
STZ icon
328
Constellation Brands
STZ
$23.2B
$680K 0.1%
4,111
-24,001
-85% -$3.76M
ONC
329
BeOne Medicines Ltd
ONC
$38.7B
$678K 0.1%
+22,751
New +$667K
NVR icon
330
NVR
NVR
$17B
$677K 0.1%
380
-894
-70% -$1.53M
CI icon
331
Cigna
CI
$74.6B
$676K 0.1%
5,284
-8,832
-63% -$1.17M
BUD icon
332
AB InBev
BUD
$165B
$673K 0.09%
+5,108
New +$643K
CLLS
333
Cellectis
CLLS
$285M
$672K 0.09%
25,254
-24,616
-49% -$722K
WVE icon
334
Wave Life Sciences
WVE
$1.2B
$669K 0.09%
+32,332
New +$504K
SEE
335
DELISTED
Sealed Air
SEE
$665K 0.09%
+14,466
New +$691K
CACC icon
336
Credit Acceptance
CACC
$6.08B
$661K 0.09%
3,569
-6,731
-65% -$1.23M
CLDX icon
337
Celldex Therapeutics
CLDX
$3.27B
$661K 0.09%
10,043
+3,863
+63% +$245K
EXP icon
338
Eagle Materials
EXP
$6.57B
$660K 0.09%
+8,553
New +$646K
MKSI icon
339
MKS Inc
MKSI
$20.6B
$659K 0.09%
15,296
-8,684
-36% -$337K
KITE
340
DELISTED
Kite Pharma, Inc.
KITE
$657K 0.09%
13,147
-7,319
-36% -$360K
HD icon
341
Home Depot
HD
$355B
$652K 0.09%
5,110
-11,668
-70% -$1.54M
LEN icon
342
Lennar Class A
LEN
$21.2B
$650K 0.09%
14,823
-31,998
-68% -$1.4M
GTT
343
DELISTED
GTT Communications, Inc.
GTT
$647K 0.09%
34,999
-98,801
-74% -$1.67M
ADXS
344
DELISTED
Advaxis Inc
ADXS
$646K 0.09%
5,323
-3,871
-42% -$496K
SABR icon
345
Sabre
SABR
$818M
$643K 0.09%
+24,017
New +$675K
EXPE icon
346
Expedia Group
EXPE
$37.3B
$641K 0.09%
+6,030
New +$655K
IBRX icon
347
ImmunityBio
IBRX
$8.1B
$638K 0.09%
102,500
+12,056
+13% +$93.6K
ZBH icon
348
Zimmer Biomet
ZBH
$18.4B
$635K 0.09%
+5,432
New +$615K
GD icon
349
General Dynamics
GD
$106B
$632K 0.09%
4,542
-10,478
-70% -$1.46M
WTW icon
350
Willis Towers Watson
WTW
$32B
$631K 0.09%
+5,080
New +$627K
12 13
14
15 16

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q2 2016 Portfolio in Review

As of Q2 2016, Vident Investment Advisory held 408 positions worth $712M, up 43,807% from $1.62M the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

Vident Investment Advisory withdrew a net $649M in Q2 2016, closing 32 positions and reducing 332 holdings. Its most notable exit was Allergan plc, an estimated $11.2K position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Vident Investment Advisory opened a new position in State Street SPDR S&P 500 ETF Trust worth $9.68M.

  • Vident Investment Advisory's largest Q2 2016 buy was State Street SPDR S&P 500 ETF Trust: 46,190 shares worth $9.68M.
  • Vident Investment Advisory added most to Meta Platforms (Facebook) in Q2 2016, an estimated $1.05M increase.
  • Vident Investment Advisory's biggest Q2 2016 reduction was Amazon, cutting an estimated $14.4M.
  • Vident Investment Advisory fully exited Allergan plc in Q2 2016, selling an estimated $11.2K.
  • Vident Investment Advisory's ten largest holdings make up 6.9% of its $712M portfolio in Q2 2016.
  • Vident Investment Advisory opened 37 new positions and closed 32 in Q2 2016.
  • Vident Investment Advisory's portfolio value rose 43,807% quarter-over-quarter to $712M.

Based on Vident Investment Advisory's 13F filing for Q2 2016, filed 12 Aug 2016.